Skip Navigation

ALS News: May 2017

field with sun shining

May 11
2017
Breaking Research
The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease
Rea entire press release on www.fda.gov